Ligand validation:6RV2

PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PC1 is a Ligand Of Interest in 6RV2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RV2_PC1_D_601	3%	89%	0.323	0.711	0.27	0.37	-	-	0	0	70%	0.7037
6RV2_PC1_D_604	3%	90%	0.3	0.734	0.33	0.28	-	-	0	0	39%	0.3889
6RV2_PC1_A_308	3%	90%	0.329	0.717	0.25	0.36	-	-	0	0	59%	0.5926
6RV2_PC1_B_304	2%	92%	0.363	0.766	0.26	0.26	-	-	0	0	33%	0.3333
6RV4_PC1_C_305	8%	93%	0.242	0.827	0.25	0.25	-	-	0	0	39%	0.3889
2Z73_PC1_B_1004	29%	34%	0.182	0.889	1.64	0.97	2	1	1	0	72%	0.7222
3WGV_PC1_D_3003	28%	44%	0.226	0.877	0.95	1.21	5	5	1	0	100%	1
3EAM_PC1_E_601	25%	24%	0.202	0.863	1.43	1.69	4	6	0	1	87%	0.8704
1BP1_PC1_A_777	22%	52%	0.246	0.864	1.06	0.79	2	2	10	0	100%	1
8JBK_PC1_A_1111	16%	59%	0.321	0.891	0.7	0.86	-	1	8	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.